Aditxt, Inc. Other Finite-Lived Intangible Assets, Gross
Aditxt, Inc. (ADTX) had Other Finite-Lived Intangible Assets, Gross of $331.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization › Intangible Asset, Finite-Lived, before Accumulated Amortization
us-gaap:OtherFiniteLivedIntangibleAssetsGross · last filed 2026-05-20
- 2026-03-31: Other Finite-Lived Intangible Assets, Gross $331.00K.
- 2025-12-31: Other Finite-Lived Intangible Assets, Gross $331.00K.
- 2025-09-30: Other Finite-Lived Intangible Assets, Gross $331.00K.
- 2025-06-30: Other Finite-Lived Intangible Assets, Gross $331.00K.
| Period end | Other Finite-Lived Intangible Assets, Gross | Other Finite-Lived Intangible Assets, Gross as first filed |
|---|---|---|
| 2026-03-31 | $331.00K 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $331.00K 10-Q · filed 2026-05-20 | |
| 2025-09-30 | $331.00K 10-Q · filed 2025-11-18 | |
| 2025-06-30 | $331.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $331.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $331.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $321.00K 10-Q · filed 2024-11-18 | |
| 2024-06-30 | $321.00K 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $321.00K 10-Q · filed 2024-05-20 | |
| 2023-12-31 | $331.00K 10-K · filed 2025-03-31 | $321.00K 10-Q · filed 2024-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |